SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.

Shaye Wolf, Center for Biological Diversity, (415) 632-5301
Todd Steiner or Teri Shore, Turtle Island Restoration Network, (415) 663-8590 x 103 or 104
The Center for Biological Diversity and Turtle Island
Restoration Network filed a formal notice today that they intend to sue the
Obama administration for illegally delaying protection of penguins under the
Endangered Species Act. The Department of the Interior failed to meet the
December 19, 2009 legal deadline to finalize the listings of seven penguin
species that are threatened by climate change and industrial fisheries. Until
the listings are finalized, these penguins will not receive the Endangered
Species Act protections they need to recover.
"While
sea ice melts away and the oceans warm, the Obama administration is frozen in
inaction. Instead of protecting penguins and taking meaningful steps to address
global warming," said Shaye Wolf, a biologist with the Center for
Biological Diversity, "our government is dragging its feet while penguins
are marching toward extinction."
"Penguins
face a double whammy from the threats brought by climate change and industrial
fisheries that deplete the penguins' food supply and entangle and drown
the penguins in longlines and other destructive fishing gear. They deserve
protection under the Endangered Species Act," said Todd Steiner,
executive director of Turtle Island Restoration Network.
In 2006 the Center filed a petition to list 12 penguin
species under the U.S. Endangered Species Act. In December 2008, the Interior
Department proposed listing seven penguin species as threatened or endangered
- African, Humboldt, yellow-eyed, white-flippered, Fiordland crested, and
erect-crested penguins and a few populations of the southern rockhopper penguin
- while denying listing to emperor and northern rockhopper penguins
despite scientific evidence that these penguins are threatened by climate
change.
While today's notice challenges the Interior
Department's illegal delay in finalizing the listing of seven penguin
species, the Center and Turtle Island Restoration Network also intend to file
suit against the Interior Department for unlawfully denying Endangered Species
Act protections to emperor and rockhopper penguins.
"So far the Obama administration has done even less
for penguins than Bush did," said Wolf. "Interior Secretary Salazar
seems unwilling to complete the final steps to protect some penguin species
started by the Bush administration, let alone correct the Bush
administration's illegal denial of protection to the emperor penguin.
Where's the change we were promised?"
Climate
change and industrial fisheries pose the primary threats to penguins, although
many species of these charismatic birds also face threats from oil pollution,
predators, and habitat destruction. Warming oceans and diminished sea ice have
wreaked havoc on penguin food availability. For example, krill, an essential
food source not just for penguins but also for whales and seals, has declined
by as much as 80 percent since the 1970s over large areas of the Southern Ocean
with the loss of sea ice. Less food has led to population declines in species
ranging from the southern rockhopper and Humboldt penguins of the islands off
South America to the African penguin in southern Africa.
Ocean
acidification, resulting from the ocean's absorption of human-produced
carbon dioxide, is expected to produce lethal conditions for key marine
organisms at the base of the Southern Ocean food web as early as 2030, which
will have cascading effects on penguins. Industrial fisheries that deplete the
penguins' food supply and entangle and drown the penguins in fishing gear
also pose a significant threat to these unique animals.
Listing
under the Endangered Species Act would provide broad protection to penguins
from a variety of threats, raise awareness of their urgent plight, and increase
research funding. Federal approval of fishing permits for U.S.-flagged vessels
operating on the high seas would require analysis and minimization of impacts
on the listed penguins. The Act also has an important role to play in reducing
greenhouse gas pollution by compelling federal agencies to look at the impact
of the emissions generated by their activities on listed penguins and to adopt
solutions to reduce emissions.
Protecting
penguins will require national and international action to slow climate change.
Leading climate scientists have concluded that the atmospheric CO2
level must be reduced to less than 350 parts per million to prevent dangerous
climate change and protect vulnerable species like penguins. Doing so will
require the United States to cut its greenhouse gas emissions to 45 percent or
more below 1990 levels by 2020. However, President Obama pledged an
insufficient 3-percent reduction in the Copenhagen Accord.
For
more information on penguins and a link to the federal petition, please see: https://www.biologicaldiversity.org/species/birds/penguins/index.html
For
information on how penguins are harmed by climate change and on the importance
of reducing atmospheric CO2 to less than 350 parts per million, see
our "350 Reasons to Get to 350" Web page:
https://www.biologicaldiversity.org/programs/climate_law_institute/350_reasons/index.html
At the Center for Biological Diversity, we believe that the welfare of human beings is deeply linked to nature — to the existence in our world of a vast diversity of wild animals and plants. Because diversity has intrinsic value, and because its loss impoverishes society, we work to secure a future for all species, great and small, hovering on the brink of extinction. We do so through science, law and creative media, with a focus on protecting the lands, waters and climate that species need to survive.
(520) 623-5252"Just pointless forever war, death and destruction—a flailing, furious, rapidly declining superpower," one analyst wrote of the Trump administration's assault.
US President Donald Trump late Thursday threatened more illegal attacks on Iranian civilian infrastructure, including bridges and power plants, as Iran's military said it shot down an American fighter jet over Tehran, with state-affiliated media publishing apparent photos from the scene.
An Iranian official told Drop Site's Jeremy Scahill that Iran's forces hit an F-15 warplane, causing the jet to crash and sparking "an intense fire." The unnamed Iranian official said the pilot could not have evacuated due to the "nature of the strike," but "no remains have yet been found."
The US Central Command had not commented on the purported downing of an American fighter jet as of this writing. Last month, a US F-35 was forced to make an emergency landing at an air base in the Middle East after reportedly being struck by Iranian fire.
🚨 BREAKING | An Iranian official told Drop Site News that a U.S. F-15 warplane struck by Iranian forces went down over southern Tehran Province, with intense fire reported at the crash site.
The official said the nature of the strike prevented the pilot[s] from ejecting before… https://t.co/iUKD0AqRQQ pic.twitter.com/BI4TzolmZY
— Drop Site (@DropSiteNews) April 3, 2026
Iran's claim on Friday came as Trump issued more belligerent threats on his social media platform, declaring that the US military "hasn’t even started destroying what’s left in Iran."
"Bridges next, then Electric Power Plants!" the president wrote, shortly after bragging about the US military's destruction of an Iranian highway bridge. "New Regime leadership knows what has to be done, and has to be done, FAST!"
Brian Finucane, senior adviser to the US Program at the International Crisis Group, characterized Trump's message as "more threats of war crimes as POTUS flails and seeks to coerce an exit to his own self-inflicted, unnecessary, and ill-conceived war."
Trump's renewed threats came amid reports of US-Israeli attacks on a century-old Iranian medical research center, pharmaceutical facilities, residential buildings, and other civilian infrastructure—and on emergency responders aiding those wounded by the attacks.
"War crime after war crime after war crime," US Rep. Yassamin Ansari (D-Ariz.), the lone Iranian American member of Congress, wrote early Friday. "Now’s the time to speak up if you’re against this reckless war of choice. The consequences will be vast and catastrophic."
Ben Rhodes, a political analyst who worked in the Obama administration, wrote that the US military's recent actions have "nothing to do with nuclear or helping Iranians."
"Just pointless forever war, death and destruction—a flailing, furious, rapidly declining superpower," Rhodes added.
One campaigner urged the administration to "focus on real solutions to support more transparent and diverse supply sources and make targeted investments for the supply of key medicines."
On Thursday, the one-year anniversary of President Donald Trump's so-called Liberation Day, US advocacy groups sounded the alarm about his new tariffs targeting "patented pharmaceuticals and their ingredients under Section 232 of the Trade Expansion Act of 1962 to bolster American national security and public health."
The administration announced a year ago that the US Department of Commerce would conduct a related investigation under that law. The resulting report was recently sent to the president, and although the findings have not been made public, Trump's executive order summarizes key takeaways and Secretary Howard Lutnick's recommended actions.
According to the order, the secretary's recommendations included "continuing to negotiate onshoring agreements related to most favored nation (MFN) pharmaceutical pricing agreements; imposing significant tariffs on pharmaceuticals and pharmaceutical ingredients, so that such imports will not threaten to impair the national security of the United States; and granting preferential treatment to those companies that commit to onshore production of pharmaceuticals and pharmaceutical ingredients."
Citing an unnamed Trump administration official, The Washington Post reported Thursday that "the White House has reached agreements with 13 drugmakers and expects to soon conclude an additional four." As part of these deals, companies are planning to invest at least $400 billion in new US plants.
The Post also pointed out that "some imported drugs will face much lower tariffs under trade deals Trump negotiated with five US trading partners. Goods from the European Union, Japan, South Korea, and Switzerland will face 15% levies, while drugs from the United Kingdom, which was the first to sign a deal with Trump, will be hit with a 10% tariff."
Thanks to Trump's new order, brand-name pharmaceuticals made in other countries could be hit with tariffs as high as 100%.
Merith Basey, CEO of Patients for Affordable Drugs, warned in a statement that "while these tariffs aim to pressure pharmaceutical corporations into US manufacturing and most favored nation agreements, the current MFN deals remain opaque and voluntary, and have not delivered meaningful savings for the vast majority of American patients. There's a real risk these tariffs will drive up costs and create more uncertainty for millions of patients already struggling to afford their medications."
Experts at Public Citizen, another advocacy group that has sued to expose the secretive MFN agreements, were similarly critical.
"By announcing these tariffs without even producing the evidence from the investigation that supposedly justifies them, Trump is continuing his pattern of grabbing headlines by using the word 'tariff' while engaging in secretive ongoing negotiations and opaque exemptions processes that are ripe for corporate corruption," said Public Citizen Global Trade Watch director Melinda St. Louis—who also wrote a broader takedown of Trump's trade policy published Thursday by Common Dreams.
"While strategic tariffs can be used to support domestic manufacturing and good jobs, they must be paired with real public investments and support for workers' rights, which Trump has systematically undermined," she said. "Instead, he's bullying other countries like the UK into paying more for medicines, which will lead to windfall profits for Big Pharma and do nothing to reduce US prices."
Peter Maybarduk, director of Access to Medicines at Public Citizen, stressed that "Trump's tariffs will be either ineffective or harmful for what people need, which is a reliable, plentiful, affordable supply of medicine."
Also taking aim at the "secretive arrangements that allow Trump to claim specious victories on manufacturing and high drug prices," Maybarduk explained that "in reality, many manufacturing commitments claimed under the deals were part of previously planned projects and the drug pricing commitments appear designed to largely spare drug company profits rather than earnestly address affordability concerns."
"Meanwhile the administration has given drugmakers perks like lucrative vouchers to accelerate FDA review of their medicines and a promise from the Trump administration that it will bully other countries into adopting higher prescription drug prices, using tariffs as leverage," he continued, referring to the Food and Drug administration.
"If the administration wants to fix problems like medicines shortages and fragile supply chains," he argued, "it should focus on real solutions to support more transparent and diverse supply sources and make targeted investments for the supply of key medicines."
Police in Paris apprehended and briefly detained European Parliament Member Rima Hassan Thursday on suspicion of "apology for terrorism"—an allegation critics slammed as "judicial harassment" aimed at silencing her outspoken criticism of Israel's genocidal war on Gaza and the French government's support for it.
Hassan, who represents the leftist La France Insoumise (LFI, or France Unbowed in English) party in the European Parliament, was summoned as part of an investigation by the National Center for Combating Online Hate (PNLH), Le Parisiene first reported.
The newspaper also reported that "a few grams" of a synthetic drug—possibly 3-MMC—were found on Hassan, allegations that sparked skeptical reactions.
PNLH is probing a since-deleted March 26 post on the social media site X in which Hassan referred to Kōzō Okamoto, a member of the Japanese Red Army who, along with two others, killed 26 people and wounded 80 more in the name of Palestinian liberation during a 1972 massacre at Lod Airport in Israel.
Hassan, a descendant of Palestinians ethnically cleansed from their homeland during the foundation of the modern Israeli state, was born in a refugee camp in Syria and emigrated to France as a child.
The Sorbonne-educated jurist was one of the leaders of the June 2025 Gaza Freedom Flotilla Madleen mission, along with climate campaigner Greta Thunberg and others. Hassan and others aboard the Madleen were intercepted by Israeli forces and arrested in international waters as they attempted to deliver food, children’s prosthetics, and other desperately needed supplies to Gaza’s besieged and starving people. Hassan said that she was beaten in Israeli custody.
While far-right and pro-Israel French lawmakers celebrated Hassan's detention and called for her to be stripped of parliamentary immunity, Palestine defenders condemned the arrest.
"Once again, the offense of glorifying terrorism is being used to repress a Palestinian activist known worldwide for her fight against genocide," said leftist lawyer Elsa Marcel. "While Israel bombs Iran and Lebanon and colonization accelerates in the West Bank, the French state continues to repress the voices fighting for the liberation of Palestine. Immediate release!"
LFI French National Assembly Member Gabrielle Cathala voiced her "full support for Rima Hassan" in a post on X.
"In violation of her parliamentary immunity, she is currently being held in custody for a simple tweet that had nothing to do with 'apology for terrorism,'" she wrote. "This judicial harassment must stop."
"If this is already happening, just imagine what would occur in the event of a vote on the Yadan Law," Cathala added, referring to a highly controversial bill critics say would criminalize anti-Zionism by conflating opposition to Israel with animus toward Jewish people, aligning with the dubious International Holocaust Remembrance Alliance Working Definition of Antisemitism.
Soutien à ma camarade et collègue Rima Hassan, en garde à vue pour un tweet, alors que le génocide à Gaza se poursuit et que les palestinien•nes subissent désormais un apartheid par le gouvernement d’extrême droite israélien.
[image or embed]
— François Piquemal (@francoispiquemal.bsky.social) April 2, 2026 at 6:51 AM
Jean-Luc Mélenchon, the de facto LFI leader and a former European Parliament member, said on Bluesky: "The political police have once again summoned Rima Hassan for questioning regarding a retweet from March. Parliamentary immunity, then, no longer exists in France."
"It is intolerable," he added. "The Yadan Law was not passed—yet is it already being enforced?"
Hassan was previously summoned by authorities following a December 2024 complaint over social media posts, including one in which she asserted, “If Franco-Israelis are allowed to serve in the Israeli army while enjoying the gains of dual citizenship, every Franco-Palestinian must be able to join the Palestinian armed resistance, the legitimacy of which is recognized by [United Nations] resolutions on the right to self-determination of peoples."
Since she started speaking out against the Gaza genocide, Hasan has been subjected to online bullying, including death and rape threats and doxing.
Last week, Hassan was denied entry into Canada—where she was scheduled to speak at multiple conferences in Montréal and meet with left-wing pro-Palestine members of Québec's National Assembly—following concerns from the pro-Israel groups B’nai Brith Canada and the Center for Israel and Jewish Affairs. Hassan attended the conferences remotely.
“The revocation of [Hassan's] travel authorization is part of a worrying trend of restricting freedom of expression and movement of political representatives," LFI said in a statement, "as well as part of a broader pattern of censorship affecting democratic debate."
Other Palestine defenders have been targeted by the French government, including Olivia Zemor, president of the advocacy group Europalestine, who last week was hit with a 24-month suspended sentence for "apology for terrorism" due to her support for Palestinian rights.